Clinical spectrum of human retroviral-induced diseases.
Urba
W J
WJ
Longo
D L
DL
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000382:microbiology; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000914:Antibodies, Viral / Q000032:analysis*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017977:Deltaretrovirus; D005260:Female; D015483:HIV Antibodies; D006467:Hemophilia A; D006716:Homosexuality; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D007239:Infections / Q000150:complications; D007564:Japan; D007938:Leukemia / Q000150:complications / Q000453:epidemiology / Q000382:microbiology / Q000473:pathology / Q000628:therapy; D007958:Leukocyte Count; D008223:Lymphoma / Q000150:complications / Q000453:epidemiology / Q000382:microbiology / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011971:Receptors, Immunologic / Q000032:analysis / Q000276:immunology; D015375:Receptors, Interleukin-2; D012192:Retroviridae Infections / Q000453:epidemiology; D012514:Sarcoma, Kaposi / Q000150:complications / Q000628:therapy; D012871:Skin Diseases / Q000473:pathology; D019966:Substance-Related Disorders; D013601:T-Lymphocytes / Q000382:microbiology; D006377:T-Lymphocytes, Helper-Inducer / Q000382:microbiology; D014481:United States
D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D015483:HIV Antibodies; D011971:Receptors, Immunologic; D015375:Receptors, Interleukin-2